Close

Co-Diagnostics (CODX) Announces Patent for CoPrimer Technology

October 10, 2018 6:31 AM EDT Send to a Friend
Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login